Thomas A. McCourt, Director at ACCELERON PHARMA INC (XLRN), sold 46,344 shares at $90.64 ($4.2M) on 2020-09-11, disclosed to the SEC on 2020-09-15.
Open-market sale of $4.2M XLRN by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $89.98 | 9,176 | $826K | 19.7% |
| 2 | $89.98 | 9,176 | $826K | 19.7% |
| 3 | $90.64 | 13,896 | $1.3M | 30.1% |
| 4 | $90.64 | 13,896 | $1.3M | 30.1% |
| 5 | $91.38 | 200 | $18K | 0.4% |
| Total | $90.38 avg | 46,344 |
| $4.2M |
| 100% |
| Filing → |
| IRWD | SELL | 2025-02-12 | $490K | — | Filing → |
| IRWD | SELL | 2024-05-22 | $872K | — | Filing → |
| IRWD | SELL | 2024-02-14 | $5.4M | — | Filing → |